FDAs 2023 Category 2 placement cited immunogenicity risk for certain routes of administration, peptide-related impurities, complexities in active pharmaceutical ingredient (API) characterization, and limited safety information for the proposed routes
If chronic stress is a factor in your life, addressing it through stress management, therapy, or lifestyle changes will significantly improve how quickly and effectively tirzepatide suppresses your overall appetite
In contrast, SGLT2 inhibitor monotherapy is not likely to provide sufficient weight loss for treatment of obesity per se, but could have other benefits in obese patients with co-morbidities such as atherosclerotic cardiovascular disease, heart failure, or renal disease
They were bad people for whom the solution was for them to become good, says William Stauffer, executive director of Pennsylvania Recovery Organizations Alliance, who has written about the history of recovery movements
Patients should inspect their pen before each injection
Where lab data was thin or hidden, we said so plainly